CRH reported resilient Q3 2026 results but lower net income due to impairment losses; total revenue grew 3% Y/Y to $11.4 billion. The company announced a new $6 billion share buyback program and reaffirmed FY26 guidance.
CRH reported resilient Q3 2026 results but lower net income due to impairment losses; total revenue grew 3% Y/Y to $11.4 billion. The company announced a new $6 billion share buyback program and reaffirmed FY26 guidance.